Body Dysmorhpic Disorder Clinical Trial
Official title:
Internet-based Cognitive Behavior Therapy for Body Dysmorphic Disorder: A Pilot Study
Verified date | August 2017 |
Source | Karolinska Institutet |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The primary aim is to develop, and test the feasibility, of a novel and protocol-based cognitive behaviour therapy (CBT) treatment for body dysmorphic disorder (BDD) administered via the Internet.
Status | Completed |
Enrollment | 23 |
Est. completion date | March 2014 |
Est. primary completion date | March 2014 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - outpatients - male or female -= 18 years - currently living in Stockholm county - primary diagnosis of BDD according to the DSM-IV-TR - signed informed consent - regular access to a computer with Internet access and skills to use the web. Exclusion Criteria: - psychotropic medication changes within two months prior to the treatment - completed CBT for BDD within the last 12 months - BDD-YBOCS < 12 at psychiatrist visit - other primary axis I diagnosis - current substance dependence - lifetime bipolar disorder or psychosis - suicidal ideation - Axis II diagnosis that could jeopardize treatment participation - other current psychological treatment that could affect BDD symptoms |
Country | Name | City | State |
---|---|---|---|
Sweden | M46 Huddinge sjukhus, Internetpsykiatrienheten/mottagningen för tvångssyndrom | Stockholm |
Lead Sponsor | Collaborator |
---|---|
Karolinska Institutet |
Sweden,
Enander J, Ivanov VZ, Andersson E, Mataix-Cols D, Ljótsson B, Rück C. Therapist-guided, Internet-based cognitive-behavioural therapy for body dysmorphic disorder (BDD-NET): a feasibility study. BMJ Open. 2014 Sep 25;4(9):e005923. doi: 10.1136/bmjopen-2014 — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Body dysmorphic disorder symptoms | Measured after 12 weeks of treatment, and after 3 months after treatment | ||
Secondary | Functioning and life satisfaction | After 12 weeks of treatment, and 3 months after treatment | ||
Secondary | Depressive symptoms | After 12 weeks of treatment, and 3 months after treatment |